Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 15Neoplasms 4Lung Neoplasms 4Sarcoma 3Sarcoma, Ewing 2Neuroendocrine Tumors 2Desmoplastic Small Round Cell Tumor 2Stomach Neoplasms 1SCLC, Extensive Stage 1Recurrence 1Platinum-Resistant Lung Small Cell Carcinoma 1Ovarian Neoplasms 1Neutropenia 1Mesothelioma 1Leiomyosarcoma 1Glioblastoma 1Gastrointestinal Malignancies 1Gastro-enteropancreatic neuroendocrine tumor 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Solid Tumor 1Adenoma, Islet Cell 1

Interventions

trifluridine tipiracil drug combination 2pegylated granulocyte colony-stimulating factor 2trilaciclib 1plerixafor 1eravacycline 1Vancomycin 1Teicoplanin 1PM 01183 1Ofloxacin 1Metronidazole 1Meropenem 1Loratadine 1Levofloxacin 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Bevacizumab 1Amikacin 1Algorithms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × PM 01183 × 1 year × Clear all
NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
30 enrolled
Thoracic

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡